Latin America Eliquis Market Size & Outlook, 2025-2033

The eliquis market in Latin America is expected to reach a projected revenue of US$ 1,302.5 million by 2033. A compound annual growth rate of -2.1% is expected of Latin America eliquis market from 2025 to 2033.
Revenue, 2024 (US$M)
$1,417.3
Forecast, 2033 (US$M)
$1,302.5
CAGR, 2025 - 2033
-2.1%
Report Coverage
Latin America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America eliquis market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America eliquis market highlights

  • The Latin America eliquis market generated a revenue of USD 1,417.3 million in 2024.
  • The market is expected to grow at a CAGR of -2.1% from 2025 to 2033.
  • In terms of segment, atrial fibrillation (af) was the largest revenue generating indication in 2024.
  • Atrial Fibrillation (AF) is the most lucrative indication segment registering the fastest growth during the forecast period.
  • Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2033.


Latin America data book summary

Market revenue in 2024USD 1,417.3 million
Market revenue in 2033USD 1,302.5 million
Growth rate-2.1% (CAGR from 2025 to 2033)
Largest segmentAtrial fibrillation (af)
Fastest growing segmentAtrial Fibrillation (AF)
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAtrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Post-Operative VTE Prophylaxis (at-risk cases)


Other key industry trends

  • In terms of revenue, Latin America region accounted for 6.8% of the global eliquis market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,019.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Eliquis Market Companies

Name Profile # Employees HQ Website
Mylan N.V. View profile - - -
F. Hoffmann-La Roche Ltd. View profile - - -
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
GSK PLC ADR View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Latin America eliquis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eliquis market will help companies and investors design strategic landscapes.


Atrial fibrillation (af) was the largest segment with a revenue share of 54.14% in 2024. Horizon Databook has segmented the Latin America eliquis market based on atrial fibrillation (af), deep vein thrombosis (dvt), pulmonary embolism (pe), post-operative vte prophylaxis (at-risk cases) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Latin America eliquis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America eliquis market databook

  • Our clientele includes a mix of eliquis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America eliquis market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America eliquis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America eliquis market size, by country, 2021-2033 (US$M)

Latin America Eliquis Market Outlook Share, 2024 & 2033 (US$M)

Latin America eliquis market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online